Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who self-identify as Black and are 45 years of age or older with a uterus still present
- People who were assigned female sex at birth
- People who have experienced abnormal uterine bleeding or post-menopausal bleeding — this includes vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause
- People who are willing to take part in a 45-minute interview held online
Who may not be able to join:
- People who have been previously or currently diagnosed with cancer of the uterine lining (endometrial cancer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shariska Harrington, MD, Mayo Clinic in Rochester
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.